SMA Research Platform

Evidence graph for Spinal Muscular Atrophy

Biology-first target discovery
Christian Fischer / Bryzant Labs
15,945Targets
453Trials
85Drugs
7Datasets
8,004Sources
221,721Claims
232,882Evidence
73,172Hypotheses
DRUGapprovedaso

nusinersen high-dose

Mechanism

Higher-dose formulation of nusinersen (Spinraza). ASO targeting SMN2 ISS-N1 at increased dosage for enhanced efficacy.

Related claims (0)

No claims matched “nusinersen high-dose” in free-text search.

Off-Target Findings (0)

No Boltz-2 / Chai-1 off-target panel claims recorded for this drug.

Login → Command Center